BRAF and malignant colon neoplasm: On the other hand, the expression of c-FLIP can be upregulated in a STAT3-dependent manner in response to MEK inhibitors in BRAF mutated colon cancer cells56, suggesting that c-FLIP level could also be regulated at the transcriptional level via STAT3 inhibition in response to paclitaxel treatment.